Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases-Reference-Cited by-同舟云学术

Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases

Published:2017-08-17 Issue:9 Volume:21 Page:879-896
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Perucci Luiza Oliveira¹²,Sugimoto Michelle Amantéa¹³,Gomes Karina Braga¹²,Dusse Luci Maria¹²³,Teixeira Mauro Martins⁴,Sousa Lirlândia Pires¹²³

Affiliation:

1. Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

2. Programa de Pós-Graduação em Análises Clínicas e Toxicológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

3. Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

4. Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2017.1364363

Reference213 articles.

1. Resolution of inflammation: a new therapeutic frontier

2. Resolution of inflammation: the beginning programs the end